Affinity binding of glycosaminoglycans with beta(2)-microglobulin

Area of Science:

• Biochemistry
• Proteoglycan Research
• Amyloidosis Studies

Background:

• Beta (2)-microglobulin (beta 2m) amyloidosis is associated with increased tissue heparan sulfate (HS) and chondroitin sulfate (CS) proteoglycans (PGs).
• The specific binding interactions between beta 2m and these proteoglycans remain largely uncharacterized.

Purpose of the Study:

• To elucidate the binding characteristics of beta 2m with glycosaminoglycans (GAGs).
• To investigate the affinity of beta 2m and its peptides for heparin (HP) and other GAGs.
• To examine the in situ binding of beta 2m peptides to amyloid deposits.

Main Methods:

• Affinity chromatography using beta 2m- and GAG-anchored columns.
• Analysis of beta 2m and peptide binding affinities to various GAGs, including heparin (HP), HS, CS-A, CS-B, and CS-C.
• In situ examination of biotinylated beta 2m peptide binding to AA amyloid deposits using enzymatic pretreatment.

Main Results:

• Beta 2m exhibited the strongest affinity for heparin (HP) among the tested GAGs, with a dissociation constant (K(d)) of 94 microM at 0.4 M NaCl.
• Peptide-1 (residues 1-24) of beta 2m showed the highest affinity for HP (K(d) = 190 microM), and mutations in its basic amino acids significantly reduced this affinity.
• Specific binding of beta 2m peptide to AA amyloid deposits via HS and CS was confirmed in situ.

Conclusions:

• Heparin/heparan sulfate (HP/HS) plays a crucial role in the binding of the beta 2m monomer.
• These interactions are significant for the anatomic localization of beta 2m amyloid precursor protein in amyloidosis.